Fauna Bio

Our CEO & Co-Founder Ashley Zehnder I’ll be speaking at SynBioBeta on Wednesday, May 7, 4:30 - 5:15 PM. Entrepreneurial Excellence in BioPharma: Lessons from the Frontlines Join a panel of pioneering BioPharma entrepreneurs as they share their hard-earned lessons and experiences from building successful ventures in one of the most challenging and dynamic industries. This session will explore key strategies for overcoming regulatory hurdles, securing funding, navigating partnerships, and driving biopharma innovation from the lab to the marketplace. Moderator: David Kiewlich, Badass Labs Speakers: Colin Farlow, Serotiny Ashley Zehnder, Fauna Bio Lexi Rovner, 64x Bio For more information visit: https://lnkd.in/dM5VDHus

Join Kamayani G. and I for our next event in the 'Intimate Conversations' series as we have an amazing guest lined up! We are excited to be hosting Ashley Zehnder, founder of Fauna Bio, on April 17th for a conversation about her journey and work using AI-driven drug discovery based on data from 100 million years of evolved disease resistance in mammals. Spots are limited as we try to keep these events close-knit to encourage space for dialogue. A huge thank you to Capgemini, Anthony Stolis, and the team there for hosting us in their beautiful space. Link below ⬇️ ⭐ Register here: https://lu.ma/111ru280 #lifesciences #artificilintelligence #drugdiscovery

Endpoints News spoke with our CEO Ashley Zehnder at Investival Showcase this week, highlighting our and plans for a $40M Series A to expand our cardiometabolic pipeline, including our lead program in heart failure. At Fauna, we’re leveraging evolutionary #genomics to unlock novel targets for some of the world’s toughest diseases. By studying species that naturally resist or recover from conditions like heart failure, we’re discovering new biology that could lead to first-in-class therapies for human patients. Stay tuned for more updates as we advance toward the clinic. 📖 Read the full story here: https://lnkd.in/ejftzTEy #Biotech #HeartFailure #DrugDiscovery #EvolutionaryGenomics #PharmaPartnerships

🌟 Congrats to Fauna Bio co-founders Ashley Zehnder, Katharine Grabek and Linda Goodman for being named to this year’s Inc. Magazine Female Founders 500 list! 🌟 At the cutting edge of biotech, Ashley, Katie, and Linda are showing what’s possible when you combine deep scientific expertise with bold entrepreneurial vision — using evolutionary genomics and AI to unlock new treatments for human disease. Their work at Fauna Bio is rethinking what nature can teach us about resilience, health, and longevity — and it's inspiring to see their leadership recognized on a national stage. 👏 Cheers to this powerhouse team for driving innovation and for paving the way for more women founders in science and biotech. Check out the full list here: https://lnkd.in/gEb9rQb9 #FemaleFounders #Biotech #Innovation #Leadership #FaunaBio #WomenInSTEM

Our CEO Ashley Zehnder will be speaking at #SynBioBeta2025 on May 7. Join industry leaders to explore the intersection of biotech innovation, investment, and industry collaboration. Gain insights from experts on scaling synthetic biology ventures, securing strategic partnerships, and navigating financial frameworks to drive commercialization. Panel Session: Entrepreneurial Excellence in BioPharma: Lessons from the Frontlines Featuring: Colin Farlow (Serotiny), Ashley Zehnder (Fauna Bio), and Lexi Rovner (64x Bio)

🚀 2 Months Until SynBioBeta 2025! We’re excited to announce new speakers joining SynBioBeta 2025, the leading synthetic biology conference. New Speaker Lineup: 🔹 Cynthia Hong – Novartis, Director, Search & Evaluation 🔹 Jeffrey Tibbetts – Symbiont Labs, CEO 🔹 Lexi Rovner – 64x Bio, CEO & Co-founder 🔹 Karin Conde-Knape – Novo Nordisk A/S, Senior Vice President 🔹 Ronald Mathae – Evonik Operations GmbH, Director Global Project Management 🔹 Ashley Zehnder – Fauna Bio, CEO 🔹 Kosuke Fujishima – Institute of Science Tokyo (Science Tokyo), Associate Professor 🔹 Gul Dolen – University of California, Berkeley, Professor 🔹 Daniel Bryan Goodman – University of California, San Francisco, Postdoctoral Fellow 🔹 Keith Murphy – Attune Neurosciences, Inc., Co-founder & CIO 🔹 Hanadie Yousef – Juvena Therapeutics, CEO & Co-founder 🔹 Patrick Malone, MD PhD – KdT Ventures, Partner Join us May 5-8, 2025, in San Jose, California, for key industry insights and networking opportunities. 🔗 Register now! #SynBioBeta2025 #SyntheticBiology

We're excited to be a part of the upcoming The Alliance for Longevity Initiatives DC Summit 2025! Our CEO & Co-Founder Ashley Zehnder will be giving a presentation: 📅 Day 1 (April 28th) 🎤 20-minute Presentation | 🕘 11:10 AM - 11:30 AM You can check out the full agenda here: https://lnkd.in/gjGwwkkq Looking forward to connecting and sharing insights with you all! 🤝💡 #DCSummit2025 #Networking #Innovation #Longevity

LEVITY Media Group spoke with our CEO & Co-Founder Ashley Zehnder for their article on what our team has been working on: The company has created what might be the world's largest biomedical knowledge graph integrating human disease data with animal resilience. They've collected thousands of transcriptomes (showing which genes are active), proteomes (mapping proteins present), and epigenomes (revealing how genes are regulated), totaling over 46 billion sequence reads from 292 different animals, across 24 tissue types, at 21 different time points. Time points? ”We start to look at what genes that are changing at time points where we see an interesting disease reversal phenotype. Either we see a heart that is slightly damaged and repairing itself, metabolism that's massively changing, or skeletal muscle that's rebuilding, which happens during hibernation. We take samples at those very precise time points. We say, ’okay, what genes are going up, what genes are going down?’ And then we start to map that to our human disease data. Read the article by Peter Ottsjö: https://lnkd.in/ebwmfKbF

Our CEO & Co-Founder Ashley Zehnder will be speaking at the Investival Showcase USA in 3 weeks time on March 11 at 10.45 am ET. 🧬🧬 Join Fauna Bio and 400+ life-science innovators with the same shared mission – to revolutionize healthcare. 🗓️ March 10-11, 2025 📍 Miami Beach Convention Center Find out more: https://lnkd.in/eUnJhpfJ #investivalusa #biotechnology #biopharma #medicaldevices #digitalhealth

“There is no limit to what we, as women, can accomplish.” – Michelle Obama February 24th / #MentoringMonday Don’t miss this day of female empowerment, where we will lift each other up, while surrounding ourselves with overflowing encouragement and support. The Business Journal is gathering 50 of Silicon Valley’s most accomplished female leaders who will be ready and waiting to meet you and offer career advice that could change your life forever. Set to take place on the same day across the nation in 40 different cities, Mentoring Monday offers "speed-coaching" sessions to thousands of women from all stages of life. You'll have the chance to speak intimately with at least 5 of these awesome business leaders. No matter what step in your career journey you face, whether you are just graduating, or find yourself wanting a major change after a long career in a particular industry, all are welcome to attend. One thing we know for sure, you'll walk away from this experience feeling recharged and refreshed, ready to tackle whatever lies ahead. Let’s accomplish our goals together at #MentoringMonday To see a full list of Mentors and secure your spot visit https://lnkd.in/eAQP7NQr Here are a few of our Mentors who are ready to meet you! Sonja Wilkerson, Executive VP & Chief People Officer Bloom Energy Dr. Sophia Yen, MD, MPH Chief Medical Officer & Co-Founder, Pandia Health Ashley Zehnder, Co-Founder & CEO, Fauna Bio Monica Zent, CEO & Founder, ZentLaw